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Background
Three patients who received visceral-organ transplants from a single donor on the 
same day died of a febrile illness 4 to 6 weeks after transplantation. Culture, poly-
merase-chain-reaction (PCR) and serologic assays, and oligonucleotide microarray 
analysis for a wide range of infectious agents were not informative.
Methods
We evaluated RNA obtained from the liver and kidney transplant recipients. Unbiased 
high-throughput sequencing was used to identify microbial sequences not found by 
means of other methods. The specificity of sequences for a new candidate pathogen 
was confirmed by means of culture and by means of PCR, immunohistochemical, 
and serologic analyses.
Results
High-throughput sequencing yielded 103,632 sequences, of which 14 represented 
an Old World arenavirus. Additional sequence analysis showed that this new arena-
virus was related to lymphocytic choriomeningitis viruses. Specific PCR assays 
based on a unique sequence confirmed the presence of the virus in the kidneys, 
liver, blood, and cerebrospinal fluid of the recipients. Immunohistochemical analy-
sis revealed arenavirus antigen in the liver and kidney transplants in the recipients. 
IgM and IgG antiviral antibodies were detected in the serum of the donor. Serocon-
version was evident in serum specimens obtained from one recipient at two time 
points.
Conclusions
Unbiased high-throughput sequencing is a powerful tool for the discovery of patho-
gens. The use of this method during an outbreak of disease facilitated the identifi-
cation of a new arenavirus transmitted through solid-organ transplantation.
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Methods of cloning nucleic acids of microbial agents directly from clini-cal specimens offer new opportunities 
for the surveillance and discovery of pathogens. 
Molecular techniques have been used successfully 
in the identification of infectious agents such as 
the Borna disease virus, hepatitis C virus, Sin Nom-
bre virus, human herpesviruses 6 and 8, Bartonella 
henselae, Tropheryma whipplei, West Nile virus, and 
the coronavirus associated with severe acute re-
spiratory syndrome.1
The arenaviruses are enveloped, negative-strand 
RNA viruses in rodents; these viruses are most 
frequently transmitted to humans through expo-
sure to infected urine. Infection with the proto-
type virus, lymphocytic choriomeningitis virus 
(LCMV), is typically asymptomatic or associated 
with mild, transient illness; however, LCMV has 
also been implicated in aseptic meningitis.2 
Human-to-human transmission of LCMV during 
pregnancy has been reported, and infection dur-
ing the gestational period can result in fetal death, 
neurologic sequelae, and chorioretinopathy.3 Fa-
tal outbreaks of disease associated with human-
to-human transmission of LCMV in recipients of 
solid-organ transplants have also been described.4 
We report the use of unbiased DNA sequencing in 
the discovery of a new LCMV-related arenavirus 
that caused fatal disease in three recipients of or-
gans from a single donor.
Me thods
Patients and Clinical Course
Three women in Australia who were 63 years of 
age (Recipient 1), 64 years of age (Recipient 2), 
and 44 years of age (Recipient 3) received a liver 
transplant (Recipient 2) or kidney transplants 
(Recipients 1 and 3) from one male donor who 
was 57 years of age. The donor died of cerebral 
hemorrhage 10 days after returning to Australia 
from a 3-month visit to the former Yugoslavia, 
where he had traveled in rural areas. The immedi-
ate post-transplantation course in the three trans-
plant recipients was unremarkable; however, febrile 
illnesses with varying degrees of encephalopathy 
developed in all three, and they died 4 to 6 weeks 
after transplantation (Table 1). Bacterial and viral 
cultures; polymerase-chain-reaction (PCR) assays 
for herpesviruses 1 through 8, lyssavirus, influ-
enza A and B viruses, respiratory syncytial virus, 
picornavirus, adenovirus, human parainfluenza 
virus, flavivirus, alphavirus, hantavirus, polyoma-
virus, Crimean–Congo hemorrhagic fever virus, 
Rift Valley fever virus, toxoplasma, Mycobacterium 
tuberculosis, and Mycoplasma pneumoniae; and viral 
and panmicrobial oligonucleotide microarray 
analysis4 revealed no candidate pathogens.
Unbiased High-Throughput Sequencing
RNA was extracted from the brain, cerebrospinal 
fluid, serum, kidney, and liver of Recipient 1, 
who had received a kidney transplant, and from 
the cerebrospinal fluid and serum of Recipient 2, 
who had received a liver transplant. As shown in 
Figure 1, after digestion with DNase I to eliminate 
human chromosomal DNA, RNA preparations 
were amplified by means of reverse-transcriptase 
PCR (RT-PCR) with the use of random primers.5,6 
Amplification products were pooled and se-
quenced with the use of the GSL FLX platform 
(454 Life Sciences), but DNA fragmentation was 
omitted.7 After trimming to remove sequences 
derived from the amplification primer and after 
filtration to eliminate highly repetitive sequences, 
the data set was analyzed by subtracting fragments 
that matched human sequences, clustering non-
redundant sequences,8 and assembling them into 
contiguous sequences9 for direct comparison with 
the GenBank databases of nucleic acids and pro-
teins with the use of BLASTN and BLASTX soft-
ware.10 We analyzed the resulting alignments and 
assigned them to nodes in the National Center 
for Biotechnology Information taxonomy database, 
using a custom software application written in Perl 
(BioPerl, version 5.8.5).
PCR Quantitation of the Arenavirus Burden 
RNA obtained from tissues, plasma, serum, and 
cerebrospinal f luid was reverse transcribed with 
the use of random hexamers. PCR was per-
formed with the use of a SYBR Green assay (Ap-
plied Biosystems). The following cycling condi-
tions were used: 50°C for 2 minutes and 95°C 
for 10 minutes, followed by 45 cycles at 95°C for 
15 seconds and 60°C for 1 minute. Real-time 
PCR assays were performed with the following 
primer set: 5′AGTGCYTGCACAACATCGTTT3′ 
(forward) and 5′CAATGCCCAGCYTGACAAT3′ 
(reverse). Thermal cycling was performed with 
the use of an ABI 7500 real-time PCR system 
(Applied Biosystems).
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Viral Isolation and Analyses
Kidney tissue from Recipient 1 was homogenized 
in phosphate-buffered saline, centrifuged to pel-
let cellular debris, filtered, and used to inoculate 
Vero E6 cells. The cells were monitored daily by 
means of light microscopy for cytopathic effect 
and by means of RT-PCR for the presence of are-
navirus nucleic acid in supernatant. Monolayers 
of cells showing cytopathic effects that were also 
positive for arenavirus nucleic acid were fixed 
with buffered 4% paraformaldehyde for indirect 
immunofluorescence and immunohistochemical 
microscopy and with buffered 2.5% glutaralde-
hyde for thin-section electron microscopy. Rabbit 
polyclonal antiserum against Old World arenavi-
ruses, including LCMV, was used as the source of 
primary antibodies for immunohistochemical 
analysis. Secondary antibodies were alkaline phos-
phatase–conjugated goat antibodies against rab-
bit IgG.4 Immunohistochemical assays were also 
performed with the use of formalin-fixed, paraf-
fin-embedded tissue sections obtained from the 
liver and kidney of Recipient 1.
Virus-infected and noninfected (control) Vero 
E6 cells were fixed with methanol. Serum speci-
mens from the donor, from the recipients, and 
from 100 randomly chosen control recipients of 
solid-organ transplants were applied to the fixed 
cells followed by fluorescein-labeled antihuman 
IgG or IgM secondary antibodies.
Complete Genome Sequencing  
and Phylogenetic Analyses
RNA extracted from the liver in Recipient 1 was 
used as a template to clone and sequence the L and 
S segments of the virus. The gene fragments ob-
tained by means of pyrosequencing were used to 
design specific PCR primers; thereafter, consen-
sus primers were designed on the basis of align-
ments of other arenavirus sequences with the use 
of the SCPrimer program.11 
The L and S segments were assembled and se-
quenced as a series of overlapping genetic frag-
ments. Evolutionary distances between the assem-
bled segments were computed with the use of the 
Poisson correction method and expressed in units 
of amino acid substitutions per site in relation 
to arenavirus L, glycoprotein precursor, and nu-
cleoprotein amino acid segments in the Gen-
Bank database with the use of the MEGA pro-
gram.12 The percentage of replicate trees in which 
taxa clustered together in the bootstrap test (1000 
replicates) is shown next to the branches. All posi-
tions containing alignment gaps and missing data 
were eliminated only in pairwise sequence com-
parisons (see Fig. 1a, 1b, and 1c of the Supple-
mentary Appendix, available with the full text of 
this article at www.nejm.org). The nucleotide and 
amino acid homologies of each of the arenavirus 
genes (Z, L, GPC, and NP) to LCMV (the closest 
completely sequenced relative) are shown in Ta-
ble 2. The sequences are deposited in GenBank 
(accession numbers EU136038 and EU136039).
R esult s
RNA from Recipient 2, who had received a liver, 
and Recipient 1, who had received a kidney, was 
pooled and amplified for unbiased high-through-
put sequencing,7 yielding 103,632 sequence frag-
n engl j med 358;10 www.nejm.org march 6, 2008









1 63 End-stage renal failure due to 
polycystic kidney disease
Kidney Fever, sepsis, encephalopathy, 
acute tubular necrosis, graft re-
jection, radiographic evidence 
of chest infiltrates
36
2 64 Decompensated cirrhosis and 
hepatocellular cancer due 
to hepatitis C infection
Liver Fever, confusion, encephalopathy 
with myoclonus, chest infil-
trates
30
3 44 End-stage renal failure due to 
polycystic kidney disease
Kidney Fever, graft rejection, intraabdom-
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ments. The sequences recovered ranged in size 
from 45 to 337 nucleotides, with a mean length 
of 162. Sequences derived from the amplification 
primer and highly repetitive sequences were 
eliminated, yielding a net of 94,043 sequences. 
These sequences were processed with the use of 
algorithms that subtract vertebrate sequences, 
assemble contiguous sequences, and compare the 
residual nucleotide and deduced amino acid se-
quences in all six potential open reading frames 
with motifs represented in databases of microbes.
At the nucleotide level, sequence data were 
uninformative; however, BLASTX analysis of the 
deduced protein sequence revealed 14 fragments 
that were consistent with Old World arenaviruses 
(12 S-segment and 2 L-segment fragments) shar-
ing the closest relationship to LCMV.
Primers were designed for RT-PCR experiments 
to detect viral RNA in clinical specimens, assess 
the similarity of viral sequences among individual 
organs and recipients, and extend the viral se-
quence needed to facilitate characterization. Viral 
RNA was present in a total of 22 of 30 speci-
mens of tissue, blood, or cerebrospinal fluid from 
all three transplant recipients (Table 3). The se-
quence was identical in all specimens, a finding 
that was consistent with the introduction of a sin-
gle virus into all the recipients.
Fresh-frozen kidney tissue from Recipient 1 was 
homogenized and used to inoculate cultures of 
n engl j med 358;10 www.nejm.org march 6, 2008
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Figure 1. High-Throughput Sequencing Method.
PCR denotes polymerase chain reaction.
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Vero E6 cells. A cytopathic effect was observed only 
in the first passages; thereafter, morphologic char-
acteristics did not differ between infected and 
control cells. Indirect immunofluorescence assays 
with the use of polyclonal antibodies against 
arenaviruses and LCMV showed cytoplasmic dis-
tribution of viral antigen. Immunostaining of vi-
ral antigens was also seen in infected cells by 
means of an indirect immunoalkaline phosphatase 
technique (Fig. 2A). Quantitative RT-PCR assays 
showed increasing concentrations of viral nucleic 
acid with serial passage. Examination of infected 
Vero E6 cells by means of thin-section electron 
microscopy revealed extracellular particles with 
morphologic features that are characteristic of 
arenaviruses (Fig. 2B).
Immunofluorescence assays for serum antibod-
ies that are reactive with infected Vero E6 cells 
revealed virus-specific IgM and IgG antibodies 
in the donor that were consistent with acute in-
fection. Plasma and serum specimens from Re-
cipient 2 that had been collected at two time points 
19 days apart (11 days and 30 days after trans-
plantation) were available for analysis. Virus-spe-
cific IgG and IgM antibodies were detectable only 
at the second time point, consistent with sero-
conversion.
Immunohistochemical analysis of specimens 
of the liver (Fig. 3A) and kidney (Fig. 3B) obtained 
from Recipient 1 showed focal immunostaining 
of arenavirus antigens. PCR surveys of 100 ar-
chived serum or plasma specimens from solid-
organ transplant recipients who were not linked 
to the cluster and who had undergone transplan-
tation in the same city and during the same time 
period revealed no evidence of infection with this 
pathogen.
The 3301-nucleotide S-segment and 7215-nucle-
otide L-segment sequences were cloned from the 
kidney of Recipient 1 by means of PCR and se-
quenced. Phylogenetic characterization was limited 
by the paucity of available sequences deposited in 
public databases; nonetheless, L- and S-segment 
analyses were consistent with the presence of a 
new arenavirus. Whereas sequences in the nucleo-
protein and glycoprotein genes on the S segment 
were closest to the LCMV strain LE13 and M1 
and M2 isolates14 (Table 2, and Fig. 1b and 1c of 
the Supplementary Appendix), the L-segment se-
quence indicated a closer relationship to Kodoko 
virus. Strain LE was isolated in France from an 
infected fetus. M1 and M2 were isolated in Japan 
from wild mice. Kodoko virus was recently isolated 
in Africa from wild mice (Fig. 1a of the Supple-
mentary Appendix).15 Reassortment is well de-
scribed in arenaviruses and could account for 
differences in phylogenetic relationships based on 
L- and S-segment sequences. However, reassort-
ment cannot be implicated without a complete 
genomic sequence for the viruses used in these 
phylogenetic analyses.
Discussion
Two clusters of transmission of arenavirus 
through solid-organ transplantation have been 
reported.4 In each cluster, recipients linked to a 
single donor died of an unexplained infectious 
disease 9 to 76 days after transplantation. In nei-
ther cluster did the donor have a history of acute 
infectious disease or evidence of infection by PCR 
or serologic analysis; however, in one cluster, a 
pet hamster that had recently been introduced 
into the donor’s household was found to be in-
fected with the same virus that was detected in 
the recipients. LCMV was implicated after the re-
sults of viral culture and electron microscopy 
triggered specific immunohistochemical and mo-
lecular tests for arenaviruses.
In our cluster, a new arenavirus was first de-
tected through unbiased high-throughput sequenc-
ing. Thereafter, the infection was confirmed by 
means of culture, electron microscopy, and spe-
cific immunohistochemical and serologic tests. 
As in the other two reported clusters of trans-
plant-associated transmission, we detected no viral 
nucleic acids in the donor and found no history 
of acute infectious disease; however, the presence 
of IgG and IgM antibodies confirmed recent in-
fection. We were also unable to obtain any infor-
n engl j med 358;10 www.nejm.org march 6, 2008
Table 2. Nucleotide and Amino Acid Homologies of the New Arenavirus  
to Other Arenaviruses.*
Gene Accession No.  LCMV Strain Homology
Amino Acid Nucleotide
percent
GPC AB261990 M2 94 86
NP AB261990 M2 97 87
L DQ286932 Marseille 12 82 79
Z DQ286932 Marseille 12 79 72
* LCMV denotes lymphocytic choriomeningitis virus.
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mation indicating that the donor had been exposed 
to rodents; however, his history of recent travel 
suggests that he may have been infected before 
returning to Australia from southern Europe, 
where such exposure may have occurred in a 
rural area.
Although we have not fulfilled Koch’s postu-
lates, evidence implicating this new virus in the 
n engl j med 358;10 www.nejm.org march 6, 2008
Table 3. Viral RNA and Antibody Titers in the Donor and Recipients.*
Specimen
Interval between Transplantation 
and Collection of Specimens Viral RNA Antibody Titer
days copies/ml of RNA extract
Donor 
Serum 0 ND 1:80 IgG, 1:20 IgM
Spleen 0 ND NA
Pancreas 0 ND NA
Recipient 1 (kidney transplant)    
Plasma 0 ND <1:10 IgG, <1:10 IgM
Plasma 27 889,200 NP
Plasma 33 614,900 NP
Cerebrospinal fluid 33 5,500 NP
Plasma 35† 1,000,000 NP
Urine 35† 88,000,000 NA
Heart 35† 33,200 NA
Spleen 35† 52,600 NA
Liver 35† 2,362,800 NA
Lung 35† 498,600 NA
Cerebrospinal fluid 35† 63,700 NP
Serum 35† 1,440,400 <1:10 IgG, <1:10 IgM
Brain 35† 16,600 NA
Rectal swab 35† 623,200 NA
Nasal swab 35† 55,400 NA
Axillary swab 35† ND NA
Kidney 35† 85,900 NA
Recipient 2 (liver transplant)    
Plasma 12 121,900 <1:10 IgG, <1:10 IgM
Mouth swab 24 457,000 NA
Bronchoalveolar lavage 19 1,163,400 NA
Cerebrospinal fluid 24 ND NP
Plasma 24 346,200 NP
Serum 31† 347,600 1:40 IgG, 1:20 IgM
Recipient 3 (kidney transplant)    
Serum −235 ND <1:10 IgG, <1:10 IgM
Serum 0 ND NP
Serum 24 415,500 NP
Serum 28 565,100 <1:10 IgG, <1:10 IgM
* NA denotes not applicable, ND not detected, and NP not performed.
† Specimens were obtained after death. 
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outbreak of infection among patients who received 
transplants is compelling. All three recipients re-
ceived organs from the same donor and died 
within days of one another after febrile illness. 
Identical viral sequences were obtained from all 
the recipients. The virus is new and was not de-
tected in 100 organ recipients who were not linked 
to this cluster. The results of serologic analysis of 
specimens obtained from the donor were consis-
tent with recent infection, and seroconversion was 
observed in one recipient.
Unbiased high-throughput sequencing has been 
used to characterize complex mixtures of micro-
flora in environmental contexts16; we have shown 
that this strategy can be used to address a sus-
pected outbreak of infectious disease. Its use in 
the context of investigating a cluster of cases of 
acute disease associated with organ transplanta-
tion facilitated the rapid implication of a new 
arenavirus not detected by other methods. This 
technique may prove useful as a new tool in the 
identification and surveillance of pathogens in 
chronic as well as acute disease.
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Figure 2. Propagation of the New Arenavirus in Tissue 
Culture.
Panel A shows immunostaining of viral antigens in in-
fected cells by means of an indirect immunoalkaline 
phosphatase technique. Panel B shows an electron mi-
crograph of extracellular arenavirus-like virions. Parti-
cles (arrows) are round, vary in size, and have surface 
projections on the perimeter. Cellular ribosomes are 
visible within the virions. The length of the bar corre-
sponds to 100 nm.
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Figure 3. Predominantly Membranous Distribution  
of Arenavirus Antigen. 
The distribution of the arenavirus antigen is shown in 
the liver (Panel A) and kidney (Panel B) of Recipient 1. 
Formalin-fixed, par ffin-embedded tissue sections 
were incubated with polyclonal rabbit antiserum 
against lymphocytic choriomeningitis virus followed by 
alkaline phosphatase–conjugated secondary antibod-
ies against rabbit IgG.
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